• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

制备用于支持能力验证计划的质量控制材料的 Leukopak PBMC 样品处理。

Leukopak PBMC sample processing for preparing quality control material to support proficiency testing programs.

机构信息

Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA.

Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA; Departments of Surgery, Duke University Medical Center, Durham, NC, USA; Duke Global Health Institute, Duke University Medical Center, Durham, NC, USA.

出版信息

J Immunol Methods. 2014 Jul;409:99-106. doi: 10.1016/j.jim.2014.05.019. Epub 2014 Jun 10.

DOI:10.1016/j.jim.2014.05.019
PMID:24928650
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4138237/
Abstract

External proficiency testing programs designed to evaluate the performance of end-point laboratories involved in vaccine and therapeutic clinical trials form an important part of clinical trial quality assurance. Good clinical laboratory practice (GCLP) guidelines recommend both assay validation and proficiency testing for assays being used in clinical trials, and such testing is facilitated by the availability of large numbers of well-characterized test samples. These samples can be distributed to laboratories participating in these programs and allow monitoring of laboratory performance over time and among participating sites when results are obtained with samples derived from a large master set. The leukapheresis procedure provides an ideal way to collect samples from participants that can meet the required number of cells to support these activities. The collection and processing of leukapheresis samples require tight coordination between the clinical and laboratory teams to collect, process, and cryopreserve large number of samples within the established ideal time of ≤8 hours. Here, we describe our experience with a leukapheresis cryopreseration program that has been able to preserve the functionality of cellular subsets and that provides the sample numbers necessary to run an external proficiency testing program.

摘要

旨在评估参与疫苗和治疗性临床试验的终点实验室表现的外部能力测试计划是临床试验质量保证的重要组成部分。良好的临床实验室规范(GCLP)指南建议对临床试验中使用的检测方法进行检测验证和能力测试,并且可以通过提供大量特征良好的测试样本来促进这种测试。这些样本可以分发给参与这些计划的实验室,并允许在使用来自大型主集的样本获得结果时,对实验室的性能进行随时间和参与站点的监测。白细胞分离术提供了一种从参与者中收集样本的理想方法,这些样本可以满足支持这些活动所需的细胞数量。白细胞分离术样本的采集和处理需要临床和实验室团队之间的紧密协调,以便在规定的理想时间内(≤8 小时)采集、处理和冷冻保存大量样本。在这里,我们描述了我们在白细胞分离冷冻保存计划方面的经验,该计划能够保持细胞亚群的功能,并提供运行外部能力测试计划所需的样本数量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41bc/4138237/8d5963b7079e/nihms603904f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41bc/4138237/f1927c8dae52/nihms603904f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41bc/4138237/1a9748919594/nihms603904f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41bc/4138237/be59b6dceecc/nihms603904f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41bc/4138237/af1fb4765fd5/nihms603904f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41bc/4138237/8d5963b7079e/nihms603904f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41bc/4138237/f1927c8dae52/nihms603904f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41bc/4138237/1a9748919594/nihms603904f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41bc/4138237/be59b6dceecc/nihms603904f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41bc/4138237/af1fb4765fd5/nihms603904f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41bc/4138237/8d5963b7079e/nihms603904f5.jpg

相似文献

1
Leukopak PBMC sample processing for preparing quality control material to support proficiency testing programs.制备用于支持能力验证计划的质量控制材料的 Leukopak PBMC 样品处理。
J Immunol Methods. 2014 Jul;409:99-106. doi: 10.1016/j.jim.2014.05.019. Epub 2014 Jun 10.
2
Establishment and maintenance of a PBMC repository for functional cellular studies in support of clinical vaccine trials.建立和维护 PBMC 库,以支持临床疫苗试验的功能细胞研究。
J Immunol Methods. 2014 Jul;409:107-16. doi: 10.1016/j.jim.2014.04.005. Epub 2014 Apr 29.
3
Benefits of a comprehensive quality program for cryopreserved PBMC covering 28 clinical trials sites utilizing an integrated, analytical web-based portal.利用集成的、基于网络的分析门户,为覆盖 28 个临床试验站点的冷冻 PBMC 实施全面质量计划的益处。
J Immunol Methods. 2014 Jul;409:9-20. doi: 10.1016/j.jim.2014.03.024. Epub 2014 Apr 4.
4
The Center for HIV/AIDS Vaccine Immunology (CHAVI) multi-site quality assurance program for cryopreserved human peripheral blood mononuclear cells.HIV/AIDS 疫苗免疫学研究中心(CHAVI)用于冷冻保存人外周血单个核细胞的多站点质量保证计划。
J Immunol Methods. 2014 Jul;409:21-30. doi: 10.1016/j.jim.2014.05.013. Epub 2014 Jun 5.
5
Implementation of Good Clinical Laboratory Practice (GCLP) guidelines within the External Quality Assurance Program Oversight Laboratory (EQAPOL).在外部质量保证计划监督实验室(EQAPOL)中实施良好临床实验室实践(GCLP)指南。
J Immunol Methods. 2014 Jul;409:91-8. doi: 10.1016/j.jim.2013.09.012. Epub 2013 Oct 9.
6
Development of a contemporary globally diverse HIV viral panel by the EQAPOL program.EQAPOL 项目开发的当代全球多样化 HIV 病毒面板。
J Immunol Methods. 2014 Jul;409:117-30. doi: 10.1016/j.jim.2014.01.004. Epub 2014 Jan 19.
7
The Immunology Quality Assessment Proficiency Testing Program for CD3⁺4⁺ and CD3⁺8⁺ lymphocyte subsets: a ten year review via longitudinal mixed effects modeling.CD3⁺4⁺和 CD3⁺8⁺淋巴细胞亚群的免疫学质量评估能力验证计划:通过纵向混合效应模型的十年回顾。
J Immunol Methods. 2014 Jul;409:82-90. doi: 10.1016/j.jim.2014.05.017. Epub 2014 Jun 7.
8
Introduction to a Special Issue of the Journal of Immunological Methods: Building global resource programs to support HIV/AIDS clinical trial studies.《免疫学方法杂志》特刊介绍:建立全球资源计划,以支持艾滋病毒/艾滋病临床试验研究。
J Immunol Methods. 2014 Jul;409:1-5. doi: 10.1016/j.jim.2014.05.016. Epub 2014 Jun 6.
9
The External Quality Assurance Oversight Laboratory (EQAPOL) proficiency program for IFN-gamma enzyme-linked immunospot (IFN-γ ELISpot) assay.干扰素-γ 酶联免疫斑点(IFN-γ ELISpot)检测外部质量保证监督实验室(EQAPOL)能力验证计划。
J Immunol Methods. 2014 Jul;409:31-43. doi: 10.1016/j.jim.2014.03.017. Epub 2014 Mar 28.
10
Development and implementation of a proficiency testing program for Luminex bead-based cytokine assays.基于 Luminex bead 的细胞因子检测能力验证计划的开发和实施。
J Immunol Methods. 2014 Jul;409:62-71. doi: 10.1016/j.jim.2014.04.011. Epub 2014 May 4.

引用本文的文献

1
The Efficiency of Brain-Derived Neurotrophic Factor Secretion by mRNA-Electroporated Regulatory T Cells Is Highly Impacted by Their Activation Status.经mRNA电穿孔的调节性T细胞分泌脑源性神经营养因子的效率受其活化状态的高度影响。
Eur J Immunol. 2025 Feb;55(2):e202451005. doi: 10.1002/eji.202451005. Epub 2024 Dec 19.
2
Evolution of the clinical-stage hyperactive TcBuster transposase as a platform for robust non-viral production of adoptive cellular therapies.临床阶段过表达 TcBuster 转座酶的进化作为一种稳健的非病毒生产过继细胞疗法的平台。
Mol Ther. 2024 Jun 5;32(6):1817-1834. doi: 10.1016/j.ymthe.2024.04.024. Epub 2024 Apr 16.
3

本文引用的文献

1
Hyperleukocytosis, leukostasis and leukapheresis: practice management.高白细胞血症、白细胞淤滞和白细胞分离术:实践管理。
Blood Rev. 2012 May;26(3):117-22. doi: 10.1016/j.blre.2012.01.003. Epub 2012 Feb 23.
2
Optimization of storage and shipment of cryopreserved peripheral blood mononuclear cells from HIV-infected and uninfected individuals for ELISPOT assays.优化 HIV 感染者和未感染者来源的冻存外周血单个核细胞的储存和运输,以用于 ELISPOT 检测。
J Immunol Methods. 2010 Dec 15;363(1):42-50. doi: 10.1016/j.jim.2010.09.032. Epub 2010 Oct 1.
3
Evaluation and recommendations on good clinical laboratory practice guidelines for phase I-III clinical trials.
Self-assembling peptide nanofiber HIV vaccine elicits robust vaccine-induced antibody functions and modulates Fc glycosylation.
自组装肽纳米纤维 HIV 疫苗可引发强大的疫苗诱导抗体功能,并调节 Fc 糖基化。
Sci Adv. 2022 Sep 23;8(38):eabq0273. doi: 10.1126/sciadv.abq0273.
4
Vaccine-Induced, High-Magnitude HIV Env-Specific Antibodies with Fc-Mediated Effector Functions Are Insufficient to Protect Infant Rhesus Macaques against Oral SHIV Infection.疫苗诱导的、具有 Fc 介导的效应功能的高滴度 HIV Env 特异性抗体不足以保护婴儿恒河猴免受口服 SHIV 感染。
mSphere. 2022 Feb 23;7(1):e0083921. doi: 10.1128/msphere.00839-21.
5
Broadly binding and functional antibodies and persisting memory B cells elicited by HIV vaccine PDPHV.HIV疫苗PDPHV引发的广泛结合且具有功能的抗体和持续存在的记忆B细胞。
NPJ Vaccines. 2022 Feb 9;7(1):18. doi: 10.1038/s41541-022-00441-9.
6
Microfluidic Squeezing Enables MHC Class I Antigen Presentation by Diverse Immune Cells to Elicit CD8 T Cell Responses with Antitumor Activity.微流控挤压使多种免疫细胞能够呈递 MHC I 类抗原,从而引发具有抗肿瘤活性的 CD8 T 细胞应答。
J Immunol. 2022 Feb 15;208(4):929-940. doi: 10.4049/jimmunol.2100656. Epub 2022 Jan 28.
7
Potent, Selective CARs as Potential T-Cell Therapeutics for HPV-positive Cancers.强效、选择性的嵌合抗原受体作为 HPV 阳性癌症的潜在 T 细胞治疗方法。
J Immunother. 2021 Oct 1;44(8):292-306. doi: 10.1097/CJI.0000000000000386.
8
A multivariate, quantitative assay that disentangles key kinetic parameters of primary human T cell function in vitro.一种多元、定量的检测方法,可以体外分离原代人 T 细胞功能的关键动力学参数。
PLoS One. 2020 Nov 9;15(11):e0241421. doi: 10.1371/journal.pone.0241421. eCollection 2020.
9
SMAC Mimetic Plus Triple-Combination Bispecific HIVxCD3 Retargeting Molecules in SHIV.C.CH505-Infected, Antiretroviral Therapy-Suppressed Rhesus Macaques.SMAC 模拟物增强型三联双特异性 HIVxCD3 重定向分子在感染 SHIV.C.CH505、抗逆转录病毒治疗抑制的恒河猴中的作用。
J Virol. 2020 Oct 14;94(21). doi: 10.1128/JVI.00793-20.
10
Redirection of Cord Blood T Cells and Natural Killer Cells for Elimination of Autologous HIV-1-Infected Target Cells Using Bispecific DART® Molecules.利用双特异性 DART®分子重定向脐血 T 细胞和自然杀伤细胞以清除自体 HIV-1 感染的靶细胞。
Front Immunol. 2020 Apr 21;11:713. doi: 10.3389/fimmu.2020.00713. eCollection 2020.
关于I - III期临床试验的良好临床实验室规范指南的评估与建议。
PLoS Med. 2009 May 26;6(5):e1000067. doi: 10.1371/journal.pmed.1000067. Epub 2009 May 5.
4
Variation in protein levels obtained from human blood cells and biofluids for platelet, peripheral blood mononuclear cell, plasma, urine and saliva proteomics.从人血细胞和生物体液中获得的血小板、外周血单个核细胞、血浆、尿液和唾液蛋白质组学的蛋白质水平变化。
Genes Nutr. 2009 Jun;4(2):95-102. doi: 10.1007/s12263-009-0121-x. Epub 2009 Apr 29.
5
Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials.为HIV疫苗试验中冷冻保存的抗原特异性反应的最佳检测确定血液处理参数。
J Immunol Methods. 2007 Apr 30;322(1-2):57-69. doi: 10.1016/j.jim.2007.02.003. Epub 2007 Feb 28.
6
Leukocyte and platelet collection from normal donors with the continuous flow blood cell separator.使用连续流动血细胞分离仪从正常供体采集白细胞和血小板。
Transfusion. 1971 Mar-Apr;11(2):94-101. doi: 10.1111/j.1537-2995.1971.tb04383.x.